Patients with inflammatory bowel disease-associated colorectal cancer appeared to have worse survival than patients with sporadic CRC, mostly due to survival differences among younger patients, according to study results.
Jessica Bogach, MD, from the department of surgery at McMaster University in Canada, and colleagues wrote in Inflammatory Bowel Diseases that studies looking at survival outcomes for patients with IBD and CRC are inconsistent because of the role of chronic inflammation.
“There are differences in the rate of disease progression, the order of mutations, and the activation

Source link